Literature DB >> 26498121

Synthesis and antimicrobial evaluation of novel 4-amino-6-(1,3,4-oxadiazolo/1,3,4-thiadiazolo)-pyrimidine derivatives.

Poornima Shetty1, B M Praveen2, M Raghavendra3, K Manjunath4, Srinivas Cheruku1.   

Abstract

A series of novel 4-amino-6-(1,3,4-oxadiazolo/1,3,4-thiadiazolo)-pyrimidine derivatives of biological interest were prepared by sequential amination, hydrazide formation, and hydrazine carbothioamidination followed by cyclization. All the synthesized compounds (6a-6h and 7a-7f) were screened for antibacterial and antifungal activity. From this group, compound 7f (MIC (μg/mL μg/mL )/Inhibition (mm): 6.25/23-30) showed good antibacterial and antifungal activity. Reagents and conditions: (a) Ethyl acetoacetate, 60% NaH, 1,4-dioxane, 60°C, 6 h; (b) DIPEA, 1,4-dioxane, 100°C, 14 h; (c) NH2NH2 ⋅ H2O, EtOH, reflux, 14 h; (d) Tolyl isothiocyanatobenzene, DMF, RT, 2 h; (e) (if X = O) EDC⋅ HCl, TEA, DMF, RT, 14 h; (f) (if X = S) Conc. H2O4, RT, 14h.

Entities:  

Keywords:  1, 3, 4-Oxadiazole; 1, 3, 4-Thiadiazole; Antibacterial; Antifungal; Pyrimidine; Thiosemicarbazide

Mesh:

Substances:

Year:  2015        PMID: 26498121     DOI: 10.1007/s11030-015-9640-0

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  16 in total

1.  Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.

Authors:  Linhong Jin; Jiang Chen; Baoan Song; Zhuo Chen; Song Yang; Qianzhu Li; Deyu Hu; Ruiqing Xu
Journal:  Bioorg Med Chem Lett       Date:  2006-07-28       Impact factor: 2.823

2.  Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.

Authors:  Roger J Gillespie; Samantha J Bamford; Alex Clay; Suneel Gaur; Tim Haymes; Philip S Jackson; Allan M Jordan; Burkhard Klenke; Stefania Leonardi; Jeanette Liu; Howard L Mansell; Sean Ng; Mona Saadi; Heather Simmonite; Gemma C Stratton; Richard S Todd; Douglas S Williamson; Ian A Yule
Journal:  Bioorg Med Chem       Date:  2009-08-05       Impact factor: 3.641

3.  Synthesis and anti-HIV activity of novel N-1 side chain-modified analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).

Authors:  R Pontikis; R Benhida; A M Aubertin; D S Grierson; C Monneret
Journal:  J Med Chem       Date:  1997-06-06       Impact factor: 7.446

4.  Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.

Authors:  Antonello Mai; Dante Rotili; Silvio Massa; Gerald Brosch; Giovanna Simonetti; Claudio Passariello; Anna Teresa Palamara
Journal:  Bioorg Med Chem Lett       Date:  2006-12-12       Impact factor: 2.823

5.  4-Aminopyrimidines as novel HIV-1 inhibitors.

Authors:  Venkat R Gadhachanda; Baogen Wu; Zhiwei Wang; Kelli L Kuhen; Jeremy Caldwell; Helmut Zondler; Harald Walter; Mark Havenhand; Yun He
Journal:  Bioorg Med Chem Lett       Date:  2006-10-10       Impact factor: 2.823

6.  Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents.

Authors:  Anu Agarwal; Kumkum Srivastava; S K Puri; Prem M S Chauhan
Journal:  Bioorg Med Chem       Date:  2005-08-01       Impact factor: 3.641

7.  Synthesis and anticonvulsant activity of new phenytoin derivatives.

Authors:  S Botros; Nadia A Khalil; Bassem H Naguib; Yara El-Dash
Journal:  Eur J Med Chem       Date:  2012-11-29       Impact factor: 6.514

8.  Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates.

Authors:  R V Chikhale; R P Bhole; P B Khedekar; K P Bhusari
Journal:  Eur J Med Chem       Date:  2009-02-27       Impact factor: 6.514

9.  Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.

Authors:  Metin Koparir; Cahit Orek; Akif Evren Parlak; Abdurrazak Söylemez; Pelin Koparir; Mustafa Karatepe; Sevgi Durna Dastan
Journal:  Eur J Med Chem       Date:  2013-03-01       Impact factor: 6.514

10.  Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.

Authors:  Georgina A Cardama; Maria J Comin; Leandro Hornos; Nazareno Gonzalez; Lucas Defelipe; Adrian G Turjanski; Daniel F Alonso; Daniel E Gomez; Pablo Lorenzano Menna
Journal:  Anticancer Agents Med Chem       Date:  2014       Impact factor: 2.505

View more
  2 in total

1.  Exploration of NMI-MsCl mediated amide bond formation for the synthesis of novel 3,5-substituted-1,2,4-oxadiazole derivatives: synthesis, evaluation of anti-inflammatory activity and molecular docking studies.

Authors:  B Kulkarni; K Manjunatha; Muthipeedika Nibin Joy; Ayyiliath Meleveetil Sajith; Sougata Santra; Grigory V Zyryanov; C N Prashantha; Mohammed B Alshammari; K Sunil
Journal:  Mol Divers       Date:  2022-10-11       Impact factor: 3.364

2.  Design, synthesis and molecular docking studies of some 1-(5-(2-fluoro-5-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-3-yl)piperazine derivatives as potential anti-inflammatory agents.

Authors:  B Kulkarni; K Manjunatha; Muthipeedika Nibin Joy; Ayyiliath Meleveetil Sajith; C N Prashantha; Ranjith Pakkath; Mohammed B Alshammari
Journal:  Mol Divers       Date:  2021-11-24       Impact factor: 3.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.